Bowhead Specialty Holdings Inc.
BOW NYSE Fire, Marine & Casualty Insurance Financials FY2022βFY2025
What Bowhead Specialty Holdings Inc. does
No business description yet.
- Legal name
- Bowhead Specialty Holdings Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001628280-26-011089
0002002473
Revenue and margins
Bowhead Specialty Holdings Inc. had $552M of revenue in fiscal 2025, up 29.6% on the year before.
Net income and earnings per share
From fiscal 2022 to 2025, diluted EPS grew 50.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $326M in fiscal 2025, 59.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Bowhead Specialty Holdings Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 13.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Bowhead Specialty Holdings Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $64.7M | $118M | $97.5M | $194M |
| Debt incl. finance leases | β | β | $0.0M | $146M |
| Debt / equity | β | β | 0.0x | 0.3x |
| Total assets | β | $1.0B | $1.7B | $2.4B |
| Total liabilities | β | $836M | $1.3B | $1.9B |
| Shareholders' equity | β | $192M | $370M | $448M |
| Net debt (β = net cash) | β | β | β$97.5M | β$47.1M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | β / 4 | β / 6 | 3 / 7 |
| Accruals ratio | β | β20.5% | β19.1% | β13.8% |
| Altman Z'' | β | β | β | β |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $188M | $283M | $426M | $552M |
| Interest expense | $0.0M | $0.0M | $0.7M | $2.0M |
| Pretax income | $14.7M | $32.1M | $50.5M | $67.3M |
| Income tax | $3.4M | $7.1M | $12.3M | $13.5M |
| Net income | $11.3M | $25.0M | $38.2M | $53.8M |
| Diluted EPS | $0.47 | $1.04 | $1.29 | $1.59 |
| Diluted shares | 0.02B | 0.02B | 0.03B | 0.03B |
| Cash flow | ||||
| Cash from operations | $182M | $236M | $294M | $332M |
| Capital expenditure | $4.0M | $3.8M | $3.1M | $5.6M |
| Free cash flow | $178M | $232M | $291M | $326M |
| Depreciation and amortization | $0.7M | $2.3M | $3.9M | $1.8M |
| Stock-based compensation | $0.4M | $0.7M | $4.1M | $7.2M |
| Balance sheet | ||||
| Cash and short-term investments | $64.7M | $118M | $97.5M | $194M |
| Total debt | β | β | $0.0M | $146M |
| Property and equipment, net | β | $7.6M | $6.8M | $10.6M |
| Total assets | β | $1.0B | $1.7B | $2.4B |
| Total liabilities | β | $836M | $1.3B | $1.9B |
| Shareholders' equity | β | $192M | $370M | $448M |
| Margins | ||||
| Net margin | 6.0% | 8.8% | 9.0% | 9.8% |
| FCF margin | 94.7% | 82.0% | 68.4% | 59.1% |
| Returns | ||||
| Return on equity | β | 13.0% | 13.6% | 13.1% |
| Return on assets | β | 2.4% | 2.9% | 2.7% |
| Return on tangible equity | β | 13.0% | 10.3% | 12.0% |
| Growth | ||||
| Revenue growth | β | 51.1% | 50.2% | 29.6% |
| Net income growth | β | 122.5% | 52.7% | 40.6% |
| EPS growth | β | 121.3% | 24.0% | 23.3% |
| FCF growth | β | 30.8% | 25.3% | 12.0% |
| Share count change | β | 0.0% | 23.7% | 13.7% |
| Financial health | ||||
| Debt / equity | β | β | 0.0x | 0.3x |
| Capital allocation | ||||
| Capex / revenue | 2.1% | 1.3% | 0.7% | 1.0% |
| Stock comp / revenue | 0.2% | 0.2% | 1.0% | 1.3% |
| Quality scores | ||||
| Piotroski F-score | β | β | β | 3.0 |
| Accruals ratio | β | β20.5% | β19.1% | β13.8% |
Source: SEC EDGAR XBRL filings (CIK 0002002473). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.